Lawsuits

The Illinois Supreme Court blocked an appeal by a prospective craft cannabis licensee asking the court to lift the state’s hold on new cannabis industry licenses.

An armored car company in California filed a lawsuit against the FBI and San Bernardino County Sheriff’s department, alleging they illegally seized cash the company was transporting for state-licensed cannabis companies.

Curaleaf has settled 10 lawsuits related to its mix-up last year of THC and CBD tinctures at a Portland, Oregon facility. Additional cases, including a wrongful death suit, are still pending.

Teva Pharmaceuticals USA Inc., the U.S. arm of a pharmaceutical firm that recently announced an international medical cannabis distribution deal, was found guilty in New York for contributing to the opioid crisis.

The state of Maine and the Maine Cannabis Coalition are appealing a judge’s ruling that dropped the medical cannabis industry’s ban on out-of-state business ownership.

NYC New York Cannabis, a New York City-based cannabis apparel brand, received an injunction from a federal judge on Tuesday for altering several of the city’s departmental logos for profit.

The tenth lawsuit against Curaleaf for a CBD/THC label mix-up involves an alleged wrongful death claim.

Delta-8 THC products will remain legal in Texas after the state Supreme Court declined to hear a case involving the legality of Delta-8 products.

A Michigan judge ruled that a portion of the recall by the Marijuana Regulatory Agency against products tested by Viridis North was “in all likelihood based upon an arbitrary decision.”

Viridis Laboratories, a cannabis testing laboratory that was recently targeted by a product recall, has filed a lawsuit against the Michigan Marijuana Regulatory Agency.

Rhode Island officials on Friday awarded five new medical cannabis licenses — one application was delayed by a lawsuit, while another was disqualified over a bribe paid to the former mayor of Fall River, Massachusetts.

The company hired by Missouri to handle cannabis licensing was successfully sued for $28 million by GMT Consulting, who said they were denied a license because the application scoring method was flawed and “corrupt.”

A judge in Florida lifted the ban stopping Leafly and other third-party websites from assisting medical cannabis dispensaries with online patient ordering.

A former compliance officer for a New Jersey cannabis business is suing his former employer claiming he was demoted because he is Black.

Actor Clint Eastwood won about $6.1 million in a lawsuit against a Lithuanian company that used Eastwood’s image and likeness to promote its CBD products without permission.

The co-founders of MedMen Enterprises are suing the co-owners of Coastal Holding Company claiming the retail dispensary chain conspired to dump the company in a liquidation sale.

An Idaho man is suing Curaleaf over a product mixup that resulted in the company’s Select-brand CBD drops being recalled last week for containing THC.

A Pennsylvania man is suing his former employer claiming the company violated the Americans with Disabilities Act and Pennsylvania Human Relations Act when he was fired for using medical cannabis.

California-based Catalyst Cannabis Co. filed a lawsuit last week against the state’s Department of Cannabis Control over product diversion due to high tax rates.

A Massachusetts cannabis dispensary won the right to operate for-profit after the state Supreme Court ruled that the town of Mansfield’s bylaws were preempted by the state’s legalization law.

California dispensary March and Ash is pushing back against the unregulated cannabis market in unincorporated San Diego County with an anti-racketeering lawsuit.

A federal judge on Wednesday said Maine cannot prohibit out-of-state companies from operating medical cannabis dispensaries in the state.

A new lawsuit claims that the Oklahoma Medical Marijuana Authority violated the state’s Open Meetings Act while enacting emergency cannabis industry regulations.

A Massachusetts lawsuit is seeking to stop the state Department of Corrections from using certain drug tests that the suit describes as faulty and with an 80% rate of false-positive tests.